Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Pooya Hemami

Pooya Hemami
Analyst

Dr Charlotte Hetzel

Dr Charlotte Hetzel
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr Linda Pomeroy

Dr Linda Pomeroy
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

Laboratorios Farmacéuticos ROVI Therapix Biosciences
NeuroVive Pharmaceutical MagForce
Arix Bioscience Formycon

Recent QuickViews

CSL

Continued growth from plasma and vaccines

Pharmaceutical & healthcare | published 03/08/2017
Rovi

Enoxaparin biosimilars - natural evolution

Pharmaceutical & healthcare | published 15/06/2017
Therapix Biosciences

Cannabinoids for underserved diseases

Pharmaceutical & healthcare | published 07/06/2017
aap Implantate

Solid start to 2017

Pharmaceutical & healthcare | published 18/05/2017

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Celyad

Gaining value on stable disease observations

ADR Update | Pharmaceutical & healthcare | 15/08/2017

The development of Celyad’s natural killer (NK) receptor-based CAR T-cell therapy (NKR-2/CYAD-01) has taken an important step with the initiation…

Celyad

Gaining value on stable disease observations

Update | Pharmaceutical & healthcare | 14/08/2017

The development of Celyad’s natural killer (NK) receptor-based CAR T-cell therapy (NKR-2/CYAD-01) has taken an important step with the initiation…

Paion

Remimazolam set for commercialisation in 2019

Update | Pharmaceutical & healthcare | 14/08/2017

Paion is well positioned to commercialise Remimazolam in 2019 for procedural sedation (via partner Cosmo Pharmaceuticals in the US) and general anaesthesia…

MagForce

Funding in place for EU roll-out

Update | Pharmaceutical & healthcare | 11/08/2017

MagForce has announced a loan of up to €35m from the European Investment Bank (EIB), of which €10m is available immediately. This funding will…

PDL BioPharma

Depomed paying off

Update | Pharmaceutical & healthcare | 10/08/2017

PDL BioPharma recently reported strong Q217 earnings mainly due to royalties related to the authorized generic of Glumetza as well as an increase in the…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies